Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: Synthesis and biological evaluation

Journal of Medicinal Chemistry

Volumn 40, Issue 24, 1997, Pages 3887-3896

  Cai, Jianping ^a   Soloway, Albert H ^a   Barth, Rolf F ^a   Adams, Dianne M ^a   Hariharan, Joya R ^a   Wyzlic, Iwona M ^a   Radcliffe, Krista ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; POLYAMINE; SPERMIDINE; SPERMINE;

ARTICLE; BRAIN TUMOR; CANCER THERAPY; CELL ACTIVITY; CYTOTOXICITY; DNA BINDING; DRUG DESIGN; GENE TARGETING; HUMAN; HUMAN TISSUE; NEUTRON CAPTURE THERAPY; TREATMENT PLANNING; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; DNA; FEMALE; GLIOMA; PREGNANCY; RATS; RATS, INBRED F344; SPERMIDINE; SPERMINE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0030778447     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960787x     Document Type: Article

References (63)

1. Locher, G. L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol. Ther. 1936, 36, 1.
2. Morin, C. The chemistry of boron analogues of biomolecules. Tetrahedron 1994, 50, 12521-12569.
3. Hawthorne, M. F. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem., Int. Ed. Engt. 1993, 32, 950-84.
4. Soloway, A. H.; Barth, R. F.; Gahbauer, R. A.; Blue, T. E.; Goodman, J. H. The rationale and requirements for the development of boron neutron capture therapy of brain tumors. J. Neuro-Oncol. 1997, 33, 9-18.
5. Mishima, Y., Ed. Cancer Neutron Capture Therapy; Plenum Press: New York, 1996.
6. Soloway, A. H., Barth, R. F. (Guest Editors). Boron neutron capture therapy of brain tumors-Gurrent status and future prospects. J. Neuro-Oncol. 1997, 33, 1-185.
7. 10B neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effect of these parameters on minimum boron content: A theoretical evaluation. Int. J. Radiat. Oncol., Biol., Phys. 1985, 11, 831-840.
8. Zamenhof, R. G.; Kalend, A. M.; Bloomer, W. D. BNCT: Looking for a few good molecules. J. Natl. Cancer Inst. 1992, 84, 1290-1291.
9. Radel, P. A.; Kahl S. B. Enantioselective synthesis of L- and D-carboranylalanine. J. Org. Chem. 1996, 61, 4582-4588.
10. Takagaki, M; Ono, J.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors. Cancer Res. 1996, 56, 2017-2020.
11. Wyzlic, I. M.; Tjarks, W.; Soloway, A. H.; Perkins, D. J.; Burgos, M.; O'Reilly, K. P. Synthesis of carboranyl amino acids, hydantoins, and barbiturates. Inorg. Chem. 1996, 35, 4541-4547.
12. Karnbrock, W.; Musiol, H. J; Moroder, L. Enantioselective synthesis of S-o-carboranylalanine via methylated bislactim ethers of 2,5-diketopiperazines. Tetrahedron 1995, 51, 1187-1196.
13. Nemoto, H.; Cai, J.; Asao, N.; Iwamoto, S.; Yamamoto, Y. Synthesis and biological properties of water-soluble p-borono-phenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake. J. Med. Chem. 1995, 38, 1673-1678.
14. Wyzlic, I. M.; Tjarks, W.; Soloway, A. H.; Anisuzzaman, A. K. M.; Rong, F-G.; Barth, R. F. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy. Int. J. Rad. Oncol. Biol. Phys. 1994, 28, 1203-1213.
15. Lesnikowski, Z. J.; Schinazi, R. F. Boron neutron capture therapy of cancers: Nucleic bases, nucleosides, and oligonucleotides as potential boron carriers. Pol. J. Chem. 1995, 69, 827-840.
16. Rong, F. G.; Soloway, A. H.; Ikeda, S.; Ives, D. Synthesis and biochemical activity of 5-tethered carborane-containing pyrimidine nuceosides as potential agents for DNA incorporation. Nucleosides Nucleotides 1995, 14, 1873-1887.
17. Chen, Y. Q.; Qu, F. C.; Zhang, Y. B. Diuridine 3′,5′-boranophosphate: Preparation and properties. Tetrahedron Lett. 1995, 36, 745-748.
18. Rong, F. G.; Soloway, A. H.; Ikeda, S.; Ives, D. H. Synthesis of 5-tethered carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation. Nucleosides Nucleotides 1994, 13, 2021-2034.
19. Goudgaon, N. M.; El-Kattan, G. F.; Schinazi, R. F. Boron containing pyrimidines, nucleosides, and oligonucleotides for neuton capture therapy. Nucleosides Nucleotides 1994, 13, 849-880.
20. Phadke, A. S.; Morgan, A. R. Synthesis of carboranyl porphyrins: Potential drugs for boron neutron capture therapy. Tetrahedron Lett. 1993, 34, 1725-1728.
21. Miura, M.; Gabel, D.; Oenbrink, G.; Fairchild R. G. Preparation of carboranyl porphyrins for boron neutron capture therapy. Tetrahedron Lett. 1990, 31, 2247-2250.
22. Kahl, S. B.; Koo, M.-S. Synthesis of tetrakis-carborane-carboxylate esters of 2,4-bis-(α,β-dihydroxyethyl)-deuteroporphyrin IX. J. Chem. Soc., Chem. Commun. 1990, 1769-1771.
23. Cai, J.; Soloway, A. H. Synthesis of carboranyl polyamines for DNA targeting. Tetrahedron Lett. 1996, 9283-9286.
24. Kelly, D. P.; Bateman, S. A.; Hook, R. J.; Martin, R. F.; Reum, M. E.; Rose, M.; Whittaker, A. R. D. DNA Binding compounds. VI. Synthesis and characterization of 2,5′-disubstituted bibenzimidazoles related to the DNA minor groove binder hoechst 33258. Aust. J. Chem. 1994, 47, 1751-1769.
25. Kelly, D. P.; Bateman, S. A.; Martin, R. F.; Reum, M. E.; Rose, M.; Whittaker, A. R. D. DNA Binding compounds. V. Synthesis and characterization of boron-containing bibenzimidazoles related to the DNA minor groove binder hoechst 33258. Aust. J. Chem. 1994, 47, 247-262.
26. Pegg, A. E.; McCann, P. P. Polyamine metabolism and function. Am. J. Physiol. (Cell Physiol. 12) 1982, C212-C221.
27. Tabor, C. W.; Tabor, H. Polyamine. Annu. Rev. Biochem. 1984, 53, 749-790.
28. Janne, J.; Poso, H. R. Polyamines in rapid growth and cancer, Biochim. Biophys. Acta 1978, 473, 241-293.
29. Moulinoux, J. P.; Darcel, F.; Quemener, V.; Havouis, R.; Seiler, N. Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation. Anticancer Res. 1991, 11, 175-180.
30. Regate, E. S.; Boggs, S.; Grudziak, A.; Deutsch, M. Polyamines in brain tumor therapy. J. Neuro-Oncol. 1995, 25, 167-179.
31. Marton, L. J.; Pegg, A. E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 55-91.
32. Bergeron, R. J. Method for the selective modification of spermidine and its homologues. Ace. Chem. Res 1986, 19, 105-113.
33. Bachrach, U. Polyamines and nucleic acids. Function of Naturally Occurring Polyamines; Academic Press: New York, 1973; pp 63-73.
34. Wemmer, D. E.; Scrivenugopal, K. S.; Reid, B. R.; Morris, D. R. Nuclear magnetic resonance studies of polyamine binding to a defined DNA sequence. J. Mol. Biol 1985, 185, 457.
35. Besley, S.; Cullis, P. M.; Partridge, R.; Symons, M. C. R.; Wheelhouse, R. T. Motion of polyammonium ions in aqueous solution of DNA. Chem. Phys. Lett. 1990, 165, 120.
36. Cohen, G. M.; Cullis, P. M.; Hartley, J. A.; Mather, A.; Symmons, M. C. Targeting of cytotoxic agents by polyamines: Synthesis of a chlorambucil-spermidine conjugate. J. Chem. Soc., Chem. Commun. 1992, 298.
37. Holley, J. L.; Mather, A.; Wheelhouse, R. T.; Cullis, P. M.; Hartley, J. A.; Binghara, J. P.; Cohen, G. M. Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res. 1992, 52, 4190-4195.
38. Li, Y.; Eisenman, J. L.; Sentz, D. L.; Rogers, F. A.; Pan, S. S.; Hu, L. T.; Egorin, M. L.; Gallery, P. S. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogues, 1,12-diaziridinyl-2,9-diazadodecane. J. Med. Chem. 1996, 39, 339-341.
39. Stark, P. A.; Thrall, B. D.; Meadows, G. G.; Abdel-Monem, M. M. Synthesis and evaluation of novel spermidine derivatives as targeted cancer chemotherapeutic agents. J. Med. Chem. 1992, 35, 4264-4269.
40. Hariharan, J. R.; Wyzlic, I. M.; Soloway, A. H. Synthesis of novel boron-containing polyamines-agents for DNA targeting in neutron capture therapy. Polyhedron 1995, 14, 823-825.
41. Hariharan, J. R. Design and synthesis of novel polyamine derivatives for boron neutron capture therapy for cancer. M.S. Thesis, The Ohio State University, Columbus, OH, 1995.
42. Zakharkin, L. I.; Kalinin, V. N. On the reaction of amines with barenes. Tetrahedron Lett. 1965, 407-409.
43. Alarcon, R. A., IV. Evidence for the formation of the cytotoxic aldehyde acrolein from enzymatically oxidized spermine or spermidine. Archives Biochem. Biophys, 1970, 137, 365.
44. Edwards, M. L.; Prakash, N. J.; Stemerick, D. M.; Sunkara, S. P.; Bitonti, A. J.; Davis, G. F.; Dumont, J. A. Polyamine analogues with antitumor activity. J. Med. Chem. 1990, 33, 1369-1375.
45. 1-acetyltransferase (SSAT) and as potential antitumor agents. J. Med. Chem. 1993, 36, 2998-3004.
46. Chantrapromma, K.; Ganem, B. Total synthesis of kukoamine A, an antihypertensive constituent of Lycium Chinenese. Tetrahedron Lett. 1981, 22, 23-24.
47. Blagbrough, I. S.; Moya, E. Total synthesis of polyamine amide spider toxin argiotoxin-636 by a practical reductive alkylation strategy. Tetrahedron Lett. 1995, 36, 9393-9396.
48. Liu, L.; Barth, R. F.; Tjarks, W.; Soloway, A. H.; Anisuzzaman, A. K. M In vitro and in vivo evaluation of carboranyl uridine as boron delivery agents for neutron caputre therapy. Anticancer Res. 1996, 16, 113.
49. Bergeron, R. J.; McManis, J. S.; Liu, C. Z.; Feng, Y.; Weimar, W. R.; Luchetta, G. R.; Wu, Q.; Ortiz-Ocasio, J.; Vinson, J. R. T.; Kramer, D.; Porter, C. Antiproliferative properties of polyamine analogues: A structure-activity study. J. Med. Chem. 1994, 37, 3464-3476.
50. Bergeron, R. J.; Neims, A. H.; McManis, J. S.; Hawthorne, T. R.; Vinson, J. R. T.; Bortell, R.; Ingeno, M. J. Synthetic polyamine analogues as antineoplasties. J. Med. Chem. 1988, 31, 1183-1190.
51. Edwards, M. L.; Snyder, R. D.; Stemerick, D. M. Synthesis and DNA-binding properties of polyamine analogues. J. Med. Chem. 1991, 34, 2414-2420.
52. Stewart, K. D. The effect of structural changes in a polyamine backbone on its DNA-binding properties. Biochem. Biopy. Res. Commun. 1988, 152 1441-1446.
53. Cain, B. F.; Baguley, B. C.; Denny, W. A. Potential antitumor agents 28. Deoxyribonucleic acid polyintercalating agents. J. Med. Chem. 1978, 21, 658-668.
54. Barth, R. F.; Adams, D. M.; Soloway, A. H.; et al. Determination of boron in tissues and cells using direct current plasma atomic emission spectroscopy. Anal. Chem. 1991, 63, 890-893.
55. Hawthorne, M. F. Biochemical applications of boron cluster chemistry. Pure Appl. Chem. 1991, 63, 327-334.
56. Grafstein, D.; Bobinski, J.; Dvorak, J.; Smith, H.; Schwartz, N.; Cohen, M. S.; Fein, M. M. Carboranes. III. Reactions of the carboranes. Inorg. Chem. 1963, 2, 1120-1124.
57. Hawthorne, M. F.; Wegner, P. A.; Stafford, R. C. Comments on the reaction of amines with 1,2-dicarbaclovododecaborane(12). Inorg. Chem. 1963, 2, 1126.
58. O'Hare, S.; Atterwill, C. K. In vitro toxicity protocols; Humana Press: Totona, NJ, 1995.
59. Ko, L.; Koestner, A.; Wechsler, W. Morphological characterization of nitrosurea-induced glioma cell line and clones. Acta Neuropathol. (Berlin; 1980, 51, 23-31.
60. Ko, L.; Koestner, A.; Wechsler, W. Characterization of cell cycle and biological parameters of transplan table glioma cell lines and cells. Acta Neuropathol. (Berlin) 1980, 51, 107-111.
61. Capala, J.; Barth, R. F.; Bendayan, M.; Lauzon, M.; Adams, D. M.; Soloway, A. H.; Fenstermaker, R. A. Carlsson, J. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjugate Chem. 1996, 7, 7-15.
62. Yong, J. H.; Barth, R. F.; Rotaru, J. H.; Wyzlic, I. M.; Soloway, A. H. Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy. Anticancer Res. 1995, 15, 2039-2044.
63. Vertosick, F. T., Jr.; Selker, R. G.; Raudall, M. S.; Kristofik, M. P.; Rehn, T. A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro. J. Neuro-Oncol. 1994, 19, 97-103.